Market revenue in 2023 | USD 188.7 million |
Market revenue in 2030 | USD 317.6 million |
Growth rate | 7.7% (CAGR from 2023 to 2030) |
Largest segment | Transbronchial needle aspiration (tbna) needles |
Fastest growing segment | Transbronchial Needle Aspiration (TBNA) Needles |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biopsy Forceps, Transbronchial Needle Aspiration (TBNA) Needles, Cytology Brushes |
Key market players worldwide | Olympus Corp, Boston Scientific Corp, Conmed Corp, Medtronic PLC, Becton Dickinson & Co, Hobbs Medical, Cook Medical, Telemed Systems, Argon Medical Devices, Horizons International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bronchial biopsy devices market will help companies and investors design strategic landscapes.
Transbronchial needle aspiration (tbna) needles was the largest segment with a revenue share of 64.23% in 2024. Horizon Databook has segmented the Asia Pacific bronchial biopsy devices market based on biopsy forceps, transbronchial needle aspiration (tbna) needles, cytology brushes covering the revenue growth of each sub-segment from 2018 to 2030.
The prevalence of respiratory diseases, including lung cancer and COPD, is rising across Asia Pacific due to high smoking rates, urban pollution, and industrialization. According to WHO, lung cancer is one of the leading causes of cancer-related deaths in several Asia Pacific countries.
For instance, the number of lung cancer cases has been increasing in China, which is expected to drive the demand for advanced diagnostic tools like bronchial biopsy devices. As per the data published by World Cancer Research Fund International, around 1060,584 new lung cancer cases were diagnosed in 2022.
In addition, governments across the region are investing in healthcare improvements as part of broader economic and social development plans. Countries like South Korea and Singapore are making substantial investments in healthcare infrastructure and technology upgrades.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific bronchial biopsy devices market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific bronchial biopsy devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account